This inventor holds 1 USPTO granted patent. Top assignee: Linxis B.v.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Sytze Jan Buwalda: Innovator in Cell-Targeting Conjugates
Introduction
Sytze Jan Buwalda is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for preparing cell-targeting conjugates. His innovative work has the potential to enhance therapeutic and diagnostic applications.
Latest Patents
Sytze Jan Buwalda holds a patent for a "Method for preparing cell targeting conjugates, and the complexes obtained." This patent outlines a method for coupling at least one functional moiety, such as a therapeutic compound, diagnostic compound, or chelating agent, to a targeting moiety. The patent also describes the cell-targeting conjugates that can be obtained through this method, as well as pharmaceutical compositions that include these conjugates. He has 1 patent to his name.
Career Highlights
Buwalda is associated with Linxis B.V., where he applies his expertise in the development of innovative pharmaceutical solutions. His work focuses on enhancing the efficacy of drug delivery systems through targeted approaches.
Collaborations
He has collaborated with notable colleagues, including Hendrik Jan Houthoff and Augustinus A M S Van Dongen, contributing to advancements in their respective fields.
Conclusion
Sytze Jan Buwalda's contributions to the field of cell-targeting conjugates exemplify the impact of innovative thinking in pharmaceuticals. His work continues to pave the way for advancements in targeted therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile